In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Bayer AG

Finance Watch: Adlai Nortye Raises $97.5m In IPO, Brings US Total To 18

Public Company Edition: Cancer-focused Adlai Nortye launched a concurrent initial public offering and private placement, while four other drug developers announced or completed SPAC mergers. Also, Sobi grossed $540m in a rights issue and Immunovant followed early data with a $450m FOPO.

Financing Business Strategies

Amicus Piggybacks Off Galafold Commercial Infrastructure For Pombiliti + Opfolda Launch

The company anticipates potential sales in excess of $1bn for the late-onset Pompe disease drug by the end of the decade.

Approvals Launches

Hengrui, Affiliate Reistone In Apparent Dispute Over China Ivarmacitinib NDAs

The future fate of Jiangsu Hengrui’s new drug discovery and development subsidiary may provide some tips on what’s ahead for the Chinese biopharma sector.

China Commercial

The Clinical Trial Accessibility Checklist: How Does Your Organization Measure Up?

This year marks the 30th anniversary of the NIH revitalization act that required women and minorities to be included in clinical research in the US. Putting that into perspective, we have only really been collecting data at scale on women and minorities since the movie Jurassic Park was launched. If we want more people to participate in clinical trials, it is time to get real about reducing the burden of research on volunteers.

Clinical Trials Diversity & Inclusion
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
    • Radiopharmaceuticals, Contrast Agents
  • Digital Health
    • Artificial Intelligence
  • Other Names / Subsidiaries
    • Actus Therapeutics, Inc.
    • AskBio
    • Asklepios BioPharmaceutical, Inc.
    • Synpromics, Ltd.
    • RoverMed BioSciences
    • NanoCor Therapeutics
    • BrainVectis
    • Algeta ASA
    • Bayer CropScience AG
    • Bayer Consumer Care AG
    • Berlex Laboratories
    • BlueRock Therapeutics
    • Conceptus Inc.
    • Dihon Pharmaceutical Group Co., Ltd.
    • Intendis GmbH
    • Jenapharm
    • Medrad Inc.
    • Possis Medical
    • Schering AG
    • Monsanto Company
    • Zeptosens AG
    • KaNDy Therapeutics
    • Vividion Therapeutics, Inc.
UsernamePublicRestriction

Register